CRVO CervoMed Inc.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1053691 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-99.9%
TTM net income YoY-11.5%
TTM EPS YoY—
Revenue 3-yr CAGR-87.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-334,924.9%
Net margin-326,822.5%
FCF margin—
EBITDA margin—
Returns
ROE-131.5%
ROA-109.8%
ROIC (approx.)-165.7%
Asset turnover0.00x
Leverage & solvency
Liabilities / assets18.6%
Debt / equity0.00x
Current ratio5.37x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.93x
Accruals ratio-7.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $4.01M | $9.74M |
| R&D expense | $21.82M | $18.80M |
| SG&A expense | $10.48M | $9.17M |
| Operating income | -$28.29M | -$18.23M |
| Income tax | $0 | — |
| Net income | -$26.97M | -$16.29M |
| EPS (basic) | -2.98 | -2.02 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $8.24M | $9.00M |
| Short-term investments | $12.63M | $29.92M |
| Current assets | $22.88M | $43.08M |
| Total assets | $22.88M | $43.08M |
| Current liabilities | $4.66M | $3.88M |
| Total liabilities | $4.66M | $3.88M |
| Shareholders' equity | $18.22M | $39.20M |
| Shares outstanding | 9.25M | 8.70M |
| Cash flow statement | ||
| Operating cash flow | -$23.45M | -$16.53M |
| Investing cash flow | $18.10M | -$28.66M |
| Financing cash flow | $4.59M | $46.40M |
| Stock-based compensation | $1.45M | $1.41M |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.